colorectal cancer

Colorectal Cancer (CRC) is Third Most Common Cancer & Fourth Most Common Cause of Cancer Death Worldwide

The global burden of colorectal cancer (CRC) is expected to increase by 60% to more than 2.2 million new cases and…

4 years ago

Cadila Pharmaceuticals expand oncology portfolio with biosimilar cancer drug Bevaro™

New Delhi, July 22, 2020: Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of Bevasizumab biosimilar for domestic market. Bevasizumab biosimilar…

4 years ago

BIOCAD and SPHagree to build a drug substance manufacturing facility in China

New Delhi, November 20, 2018: This yearat theEastern Economic Forum in Vladivostok, BIOCAD andShanghai Pharmaceuticals Holdingentered into a Memorandum of…

6 years ago

Colorectal Cancer upsurges in India, stands fourth in men and third in women.

New Delhi, November 11, 2018: It is difficult to believe that in India, just a decade ago, Cancer was not a commonly…

6 years ago

MedGenome study suggests a personalized cancer vaccine approach to treat Lynch Syndrome

National, September 06, 2018: A breakthrough study on ‘cancer vaccine approach for personalized treatment of Lynch Syndrome’ by MedGenome was…

6 years ago